In Q1, the company earned $17 million operating earnings on $2.3 billion originations. So, for the year, they should do about 4 times that. That implies $60 million in operating earnings on 13.3 million diluted shares, or about $4.50 per diluted common share.
Add the $140 million in remaining DTA to that mix and GAAP earnings surge. The stock is probably trading at about 2x forward earnings.
Since there is no analyst coverage or institutional ownership, there is nobody telling Wall Street these facts. Patience is key here.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM